| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $166K | — | +166.5% |
| SG&A Expense | $979K | — | +24.1% |
| Operating Income | -$1.1M | — | -34.5% |
| Pre-tax Income | -$1.1M | — | -90.0% |
| Net Income | -$1.1M | — | -90.0% |
| EPS (Basic) | -$0.13 | — | -30.0% |
| EPS (Diluted) | $0.13 | — | +230.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $301K | -34.4% | -87.3% |
| Current Assets | $706K | +14.0% | -75.3% |
| Total Assets | $706K | +14.0% | -75.3% |
| Current Liabilities | $2.5M | +17.7% | +123.8% |
| Total Liabilities | $2.5M | +17.7% | +123.8% |
| Stockholders' Equity | -$1.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$596K | — | +73.8% |
| Financing Cash Flow | $438K | — | -90.5% |
| -201.7% |